Project Grant R01DA062607
Award Date
6/1/25
Completion Date
2/28/30
Dollars Obligated
$816K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
This $421,200 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to design, refine, and pilot an interdisciplinary intervention to improve transitions to primary care for hospitalized patients with substance use disorders (SUDs). The primary objectives are to: 1) identify stakeholder perspectives on the optimal implementation of the intervention, 2) design and refine the intervention protocol using...
This federal Project Grant award of $1,873,868 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to design and conduct a hybrid efficacy-implementation randomized control trial to improve substance use disorder (SUD) treatment retention among pregnant patients. The key products and services to be delivered include: Developing and piloting protocols to (1) systematically address social determinants of health (SDOH) and link...
This federal Project Grant award of $459,045 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to modify the Opioid Use Disorder (OUD) Cascade of Care model to better reflect the changing landscape of real-world OUD treatment. The project will link data across healthcare and substance use treatment systems in Los Angeles County to construct a cross-system OUD care cascade, with the ultimate goal of reducing OUD-related...
This Project Grant award, totaling $181,040.00, was issued by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award aims to create an immersive training experience for the applicant to develop a unique skillset at the intersection of psychiatric genetics, substance use disorder (SUD) epidemiology and health disparities, SUD psychopharmacology, clinical informatics, and bioinformatics. The research will leverage the Million Veteran...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will assess the acceptability and feasibility of using pharmacogenomic (PGx) testing to guide opioid use disorder (OUD) treatment. The $195,728 award to Washington State University, effective January 1, 2025 through December 31, 2029, will: Identify barriers and facilitators impacting the acceptability and feasibility of a PGx testing protocol to inform OUD...
This Project Grant award, with a total funding amount of $958,629, was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The funding will support the real-world adoption of an innovative digital health therapeutic called KIOS, which uses nonlinear control theory to track multiple symptoms (e.g., craving, mood, pain) and deliver personalized, evidence-based intervention strategies to patients with opioid use disorder...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop efficient statistical methods for data fusion to improve the power and external validity of clinical trials for treating opioid use disorder. The $564,326 award, with a performance period from August 2024 to May 2029, will fund the development of new parametric and semiparametric estimators for average treatment effects,...
This $304,023 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports the development of a digital product called RESHAPE. The objective is to create a comprehensive digital experience that addresses the health-related social needs (HRSN) impacting substance use disorder (SUD) recovery. The project involves formative research, development, and large-scale deployment of the RESHAPE digital platform, which...
The National Institute on Drug Abuse (NIDA) awarded a $1,272,788.38 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the University of South Carolina to establish the PRIDE-CARES Center. The center represents a collaborative effort to address gaps in substance use disorder (SUD) research and treatment for the sexual and gender minority (SGM) community. Key objectives include: Developing a Virtual Patient Engagement (VIP) Panel to actively engage patients, family members,...
This Project Grant award of $388,857.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding a study on the direct and indirect effects of disasters on drug-related outcomes. The research aims to use quasi-experimental methods and federal disaster data to examine the impact of disasters on mortality, substance use, and related mechanisms like psychological distress and treatment disruption. The study also plans to...